Diagnostics Technology and Pandemics
Health | Resilience
BIONEER Corporation, a Biotechnology Company and Diagnostics Tool Manufacturer
Interpretation EN – KO
Diagnostics technology has proved critically essential in the fight against the COVID-19 pandemic. Quick and reliable diagnosis is key to implementing anti-virus measures. BIONEER, a Korean biotechnology company and diagnostic tool manufacturer, will present an industry perspective on how to effectively thwart the next pandemic. The session will also look back at various measures taken against COVID-19 and draw lessons to help prepare for future pandemics.
- Ms. Jiwon Lee, Assistant Researcher, BIONEER Corporation
- Dr. Kap No Lee, Chief Medical Advisor, BIONEER Corporation
- Dr. Gye Cheol Kwon, Professor, Chungnam National University Hospital
- Ms. Marta Fernández Suárez, CTO, FIND (Foundation for Innovative New Diagnostics)
- Dr. Han-Oh Park, CEO, BIONEER Corporation